![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Vectura Group Plc | LSE:VEC | London | Ordinary Share | GB00BKM2MW97 | ORD 0.0271P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 164.80 | 164.80 | 165.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/3/2021 20:50 | alord, i dont scare easily, so still holding for my divi, company seems sound, the management are just ok, but a buy out before the divi is a real possibility. | ![]() volvo | |
22/3/2021 16:06 | Who's selling? Scandalous performance again. 20% special dividend, M&A approach must be close. Board needs to be honest and come clean about approaches. | ![]() justiceforthemany | |
22/3/2021 13:45 | Thanks Paul, regardless computer article or not , share price nose diving . And analysts didn’t see any revenues from potential Advair , More payments from GSK and no forward looking generic Ellipta - looks like analysts don’t like Vectura and market makers only shorting stock. Very sad picture. Edit :The lowest price target 88p - all others above 120p , but short sellers picked up lower pt. Its why they selling ! No fair trade - total manipulation to squeeze retail. Actually 112p - 19p( divi) =93p almost target been hit. So may be bounce from here ? Hikma is slightly up today , but share price also lost a lot . On Tesla 3000$ target for 2025 - craziness ! PS Volvo and Vectura King - your optimism evaporated ? Volcano dead ? Its a shame ! | ![]() a1ord53 | |
22/3/2021 13:42 | polaris,one could almost imagine a lid is being kept on the VEC share price to make a circa 140p offer look attractive to weary shareholdersIMHO | ![]() richman777114 | |
21/3/2021 20:24 | Paul(Polaris) , please look into this yahoo article and please comment.I am disagree with opinion of mentioned in article analysts. Thx a lot in advance . PS “Covid vaccine spray could be more effective than injections, scientists say” - any idea if Vectura being cooperating on this matter ? | ![]() a1ord53 | |
21/3/2021 12:58 | I assume it would require approval at the AGM, so certainly not before then. | ![]() boadicea | |
21/3/2021 10:53 | Do we have any idea when the special may go ex-dividend? | ![]() justiceforthemany | |
20/3/2021 22:57 | yes agreed | ![]() richman777114 | |
20/3/2021 19:25 | i'd say zero chance. Even if they submitted, i'd expect it to be summarily rejected as meritless based on lower court decisions. | ![]() polaris | |
20/3/2021 17:20 | notedthink i read that the Supreme Court accepts less than 10% of petitions-something like 3%plus as you say GSK has bigger fish to fry | ![]() richman777114 | |
20/3/2021 16:37 | Richman, after Court of appeal decision by all 3 judges , it’s very difficult to petition to Supreme Court on this matter, cause it insignificant for USA.GSK reputation in US courts is not good and this petition will definitely put additional bad light on GSK. GSK has a couple of billions of US dollars litigations, which more important for them than Vectura case. Supreme Court accept only 10% of all petitions. So imo highly unlikely that they ( gsk) will risk to ruin their reputation additionly. | ![]() a1ord53 | |
20/3/2021 15:11 | polaris,thoughts on GSK possibly petitioning the Supreme Court to thwart their adversary from paying the special dividend? | ![]() richman777114 | |
20/3/2021 11:27 | I thought I should post my thoughts following my post of a few months ago. Then I assessed the probability of both the Hikma and lawsuit coming good as 25%, I was incorrect in that both are pretty much home and dry. I was also wrong with my thoughts that a reasonable price for that scenario was around £1.4, I note the price has not moved much atall. We still have the Exparel payment (I reckon 2022)to look forward to. Reading through the accounts I cant find anything to worry about and the presentation seemed pretty bullish although the CDMO transformation is yet to be proven. Disappointingly I cant find any real data on the Ellipta developments (even in Hikma data) as I still believe this is where real value lies. Valuations going forward I can see why they may be more based on a commoditised basis as unless we have more CDMO deals based on royalties as well as pay as you go that is the type of company we become. However as it is I see Vectura as undervalued and cannot see anything going forward that will change that in a market sense. Therefore I see an increased probability of predation (up from 5% to 25%). Looking at the type of predator I came across EQT as a strong contender, plenty of cash, good solid other CDMOs with good credentials in the ventilation market and a wide geographical spread. An excellent chance to consolidate into fewer sites and instant scale up in CDMO space. Anyway I am sure to be wrong but I may post other thoughts in the Summer. | ![]() andrew97 | |
20/3/2021 08:49 | FT: “Share price forecast The 6 analysts offering 12 month price targets for Vectura Group PLC have a median target of 132.00, with a high estimate of 149.00 and a low estimate of 126.00. The median estimate represents a 14.58% increase from the last price of 115.20 29.3% from 149.00 Med 14.6% from 132.00 Low 9.4% from 126.00 .” PS The lowest Price Target 10% higher than current price. Imo after GSK petition expiry and divi date announcement end of April, Advair approval share price will move above 130-35 p fast. | ![]() a1ord53 | |
19/3/2021 18:43 | 3rd Friday of the last month in the Q, where index futures and stock futures expire for multiple periods at the same time. Tends to get a bit choppy as re-balancing goes on. Pacira news is here: $500 M depends on EU launch in 2021 and how elective procedures recover in the US in the rest of the year. | ![]() polaris | |
19/3/2021 18:38 | polaris? VOLVO 19 Mar '21 - 09:11 - 11262 of 11272 Edit Any news on Pacira, again we are due 30m bonus here this year | ![]() volvo | |
19/3/2021 18:34 | Quadruple witching today - many stocks saw some significant volume at prices outside the bid-offer spread in the closing auction. | ![]() polaris | |
19/3/2021 16:54 | 117p at 1629:59 Closes at 115.2p Market needs a good deep clean; UK market in particular Continues to underperform massively due to short sellers presence | ![]() justiceforthemany | |
19/3/2021 16:52 | Thank you everyone i am a long term holder and Believe in this great company i may have got the timing wrong i look forward to that special dividend have a great weekend | vecturaking | |
19/3/2021 16:39 | Algos adjusted to FTSE 250 trading killing share price. They trading mechanically and don’t care about good news. May be get out from FTSE 250 will get rid from these Algorithms ! Nice weekend to all ! PS Vectura king , thanks for entertainment ! | ![]() a1ord53 | |
19/3/2021 16:18 | jftm, yes poor show again.....you could really tell from the presentation that CEO Downs thought he was delivering great news. | ![]() volvo | |
19/3/2021 16:16 | jftm, yes poor show again. | ![]() volvo | |
19/3/2021 16:12 | Very poor performance again. Can't see any shorts listed | ![]() justiceforthemany |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions